Literature DB >> 30986014

Time to fecal immunochemical test completion for colorectal cancer screening.

Cameron B Haas1, Amanda I Phipps, Anjum Hajat, Jessica Chubak, Karen J Wernli.   

Abstract

OBJECTIVES: Fecal immunochemical tests (FITs) can efficiently screen for colorectal cancer (CRC), but little is known on the timing to their completion. We investigate the time to return of a FIT following an order and describe patient characteristics associated with FIT return. STUDY
DESIGN: Retrospective cohort study.
METHODS: We identified 63,478 members of Kaiser Permanente Washington, aged 50 to 74 years, who received a FIT order from 2011 through 2012. Patient characteristics were ascertained through administrative and electronic health record data sources. We compared time from FIT order to return by patient characteristics using Kaplan-Meier and Cox regression methods.
RESULTS: About half (53.7%) of members completed a FIT. Median time from order to return was 13 days (mean, 44.5 days; interquartile range, 6-42 days). There was higher completion of FITs among Asian patients (hazard ratio [HR], 1.43; 95% CI, 1.38-1.48), black patients (HR, 1.13; 95% CI, 1.08-1.19), and Hispanic patients (HR, 1.10; 95% CI, 1.04-1.16) compared with white patients; among patients with recent CRC testing (vs no testing in past 2 years; HR, 1.90; 95% CI, 1.86-1.95); and among patients with Medicare insurance (vs commercial; HR, 1.30; 95% CI, 1.24-1.37). Factors associated with decreased FIT completion included younger age (50-54 years vs 70-74 years; HR, 0.87; 95% CI, 0.82-0.92), obesity (vs normal body mass index; HR, 0.88; 95% CI, 0.86-0.91), and higher Charlson Comorbidity Index score (≥3 vs 0; HR, 0.82; 95% CI, 0.79-0.87).
CONCLUSIONS: Time to return of FIT varies by patient characteristics. We observed greater FIT completion among people of color, suggesting that racial disparities in CRC may not be due to patient completion of the test after an order is received.

Entities:  

Mesh:

Year:  2019        PMID: 30986014      PMCID: PMC7170013     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  43 in total

1.  New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness.

Authors:  Ulrike Haug; Hermann Brenner
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

2.  Nonparticipation in a population-based trial to increase colorectal cancer screening.

Authors:  Beverly B Green; Andy Bogart; Jessica Chubak; Sally W Vernon; Leo S Morales; Richard T Meenan; Sharon S Laing; Sharon Fuller; Cynthia Ko; Ching-Yun Wang
Journal:  Am J Prev Med       Date:  2012-04       Impact factor: 5.043

Review 3.  Organized colorectal cancer screening in integrated health care systems.

Authors:  Theodore R Levin; Laura Jamieson; Daniel A Burley; Juan Reyes; Michael Oehrli; Cindy Caldwell
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

Review 4.  Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Deana Manassaram-Baptiste; Durado Brooks; Mary Doroshenk; Stacey Fedewa; Debbie Saslow; Otis W Brawley; Richard Wender
Journal:  CA Cancer J Clin       Date:  2015-01-08       Impact factor: 508.702

5.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

Review 6.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

7.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

8.  Gender differences in colorectal cancer screening barriers and information needs.

Authors:  Greta Friedemann-Sánchez; Joan M Griffin; Melissa R Partin
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

9.  Colorectal Cancer Screening in Switzerland: Cross-Sectional Trends (2007-2012) in Socioeconomic Disparities.

Authors:  Stacey A Fedewa; Stéphane Cullati; Christine Bouchardy; Ida Welle; Claudine Burton-Jeangros; Orly Manor; Delphine S Courvoisier; Idris Guessous
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  The role of weight, race, and health care experiences in care use among young men and women.

Authors:  Susan Persky; Hendrik D de Heer; Colleen M McBride; Robert J Reid
Journal:  Obesity (Silver Spring)       Date:  2013-12-19       Impact factor: 5.002

View more
  2 in total

1.  Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability.

Authors:  Theo Georgiou Delisle; Nigel D'Souza; Bethan Davies; Sally Benton; Michelle Chen; Helen Ward; Muti Abulafi
Journal:  BJGP Open       Date:  2022-03-22

2.  The influence of multi-morbidities on colorectal cancer screening recommendations and completion.

Authors:  Gloria D Coronado; Carrie M Nielson; Erin M Keast; Amanda F Petrik; Jerry M Suls
Journal:  Cancer Causes Control       Date:  2021-03-09       Impact factor: 2.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.